肝素诱导血小板减少症
医学
肝素
直接凝血酶抑制剂的发现与发展
重症监护医学
肾脏替代疗法
凝血酶
药理学
血小板
内科学
作者
Erik Abel,Sandra L. Kane‐Gill,Amy L. Seybert,John A. Kellum
摘要
No differences in adverse events or other clinical outcomes were observed in this retrospective evaluation of DTI use in patients receiving RRT with presumed HIT.
科研通智能强力驱动
Strongly Powered by AbleSci AI